Shopping Cart
- Remove All
- Your shopping cart is currently empty
COX-1-IN-1 (compound 15a) selectively inhibits cyclooxygenase (COX), exhibiting an IC50 of 0.23 μM for COX-1 and greater than 50 μM for COX-2, resulting in a selectivity index (COX-2 IC50/COX-1 IC50) of 217. Additionally, COX-1-IN-1 effectively inhibits platelet aggregation [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | COX-1-IN-1 (compound 15a) selectively inhibits cyclooxygenase (COX), exhibiting an IC50 of 0.23 μM for COX-1 and greater than 50 μM for COX-2, resulting in a selectivity index (COX-2 IC50/COX-1 IC50) of 217. Additionally, COX-1-IN-1 effectively inhibits platelet aggregation [1]. |
Targets&IC50 | COX-2:50 μM, COX-1:0.23 μM |
In vitro | COX-1-IN-1 inhibits arachidonic acid (AA)-induced platelet aggregation with an IC50 value of 1 μM and exhibits low cytotoxicity toward cells and platelets at 100 μM over a 3-hour incubation period [1]. Cell Cytotoxicity Assay: Cell Line: Vero; Concentration: 100 μM; Incubation Time: 3 h; Result: Demonstrated platelet and cell viabilities above 90%. |
Molecular Weight | 323.39 |
Formula | C20H21NO3 |
Cas No. | 1369503-03-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.